Brokerages expect that Trupanion Inc (NASDAQ:TRUP) will post ($0.01) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Trupanion’s earnings, with the lowest EPS estimate coming in at ($0.03) and the highest estimate coming in at $0.00. Trupanion reported earnings of $0.01 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 200%. The firm is scheduled to issue its next quarterly earnings report on Thursday, November 1st.

According to Zacks, analysts expect that Trupanion will report full year earnings of ($0.08) per share for the current fiscal year, with EPS estimates ranging from ($0.11) to ($0.05). For the next fiscal year, analysts forecast that the business will post earnings of $0.12 per share, with EPS estimates ranging from ($0.05) to $0.26. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Trupanion.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, August 2nd. The financial services provider reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.04. Trupanion had a negative net margin of 0.84% and a negative return on equity of 4.43%. The company had revenue of $73.39 million for the quarter, compared to analyst estimates of $72.70 million. During the same period last year, the firm earned ($0.02) earnings per share. The firm’s revenue was up 25.9% on a year-over-year basis.

A number of research firms recently issued reports on TRUP. BidaskClub upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a report on Tuesday, May 22nd. Canaccord Genuity raised their price objective on shares of Trupanion from $40.00 to $46.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. Lake Street Capital restated a “buy” rating and set a $46.00 price objective (up previously from $41.00) on shares of Trupanion in a report on Friday, August 3rd. Raymond James began coverage on shares of Trupanion in a report on Thursday, September 6th. They set an “outperform” rating and a $46.00 price objective for the company. Finally, Stifel Nicolaus raised their price objective on shares of Trupanion from $40.00 to $43.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $45.22.

NASDAQ TRUP opened at $33.96 on Tuesday. Trupanion has a 52-week low of $23.08 and a 52-week high of $46.70. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.04 and a quick ratio of 3.04. The stock has a market cap of $1.13 billion, a P/E ratio of -485.14 and a beta of 0.58.

In other news, insider Darryl Rawlings sold 4,000 shares of Trupanion stock in a transaction dated Monday, July 23rd. The shares were sold at an average price of $45.72, for a total value of $182,880.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Murray B. Low sold 3,000 shares of Trupanion stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $38.12, for a total transaction of $114,360.00. Following the completion of the transaction, the director now owns 189,782 shares of the company’s stock, valued at approximately $7,234,489.84. The disclosure for this sale can be found here. Insiders sold 23,450 shares of company stock valued at $908,039 in the last quarter. Corporate insiders own 20.70% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. SG Americas Securities LLC purchased a new position in shares of Trupanion in the second quarter worth about $100,000. Summit Trail Advisors LLC increased its stake in shares of Trupanion by 2,638.0% in the first quarter. Summit Trail Advisors LLC now owns 109,876 shares of the financial services provider’s stock worth $110,000 after purchasing an additional 105,863 shares in the last quarter. First Mercantile Trust Co. purchased a new position in shares of Trupanion in the second quarter worth about $142,000. US Bancorp DE increased its stake in shares of Trupanion by 111.8% in the second quarter. US Bancorp DE now owns 4,512 shares of the financial services provider’s stock worth $175,000 after purchasing an additional 2,382 shares in the last quarter. Finally, Xact Kapitalforvaltning AB purchased a new position in shares of Trupanion in the second quarter worth about $224,000. Hedge funds and other institutional investors own 94.00% of the company’s stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Featured Story: Dow Jones Industrial Average (DJIA)

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.